Loss of central auditory processing in a mouse model of canavan disease

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Von Jonquieres, Georg ^a   Froud, Kristina E ^a   Klugmann, Claudia B ^a   Wong, Ann C Y ^a   Housley, Gary D ^a   Klugmann, Matthias ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTOACYLASE; AMIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPA GENE; AUDITORY NERVOUS SYSTEM; AUDITORY PROCESSING DISORDER; AUDITORY THRESHOLD; CANAVAN DISEASE; COCHLEAR NERVE; CONTROLLED STUDY; CORTI ORGAN; DEMYELINATION; DISEASE ASSOCIATION; EVOKED BRAIN STEM AUDITORY RESPONSE; GENE; GENE DELETION; GENE FUNCTION; GENE IDENTIFICATION; MALE; MOUSE; NONHUMAN; OLIGODENDROGLIA; SCHWANN CELL; SENSORY NERVE CONDUCTION; SPIRAL GANGLION; TRANSGENIC MOUSE; WAVEFORM; ANIMAL; C57BL MOUSE; CENTRAL NERVOUS SYSTEM; DISEASE MODEL; GENETICS; HEARING; METABOLISM;

AMIDOHYDROLASES; ANIMALS; AUDITORY PERCEPTION; CANAVAN DISEASE; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL; OLIGODENDROGLIA; ORGAN OF CORTI; SCHWANN CELLS;

EID: 84901299140     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097374     Document Type: Article

References (35)

1. Kaul R, Gao GP, Balamurugan K, Matalon R (1993) Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat Genet 5: 118-123. (Pubitemid 23293445)
2. Van Bogaert L, Bertrand I (1949) Sur une idiotie familiale avec degeresce sponglieuse de neuraxe (note preliminaire). Acta Neurol Belg 49: 572-587.
3. Matalon R, Michals K, Kaul R (1995) Canavan disease: from spongy degeneration to molecular analysis. J Pediatr 127: 511-517.
4. Matalon R, Rady PL, Platt KA, Skinner HB, Quast MJ, et al. (2000) Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system. J Gene Med 2: 165-175.
5. Mersmann N, Tkachev D, Jelinek R, Roth PT, Mobius W, et al. (2011) Aspartoacylase-lacZ knockin mice: an engineered model of Canavan disease. PLoS One 6: e20336.
6. Traka M, Wollmann RL, Cerda SR, Dugas J, Barres BA, et al. (2008) Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS. J Neurosci 28: 11537-11549.
7. Klugmann M, Leichtlein CB (2006) Clinical trials of gene therapy for Canavan Disease. In: Kaplitt MG, During MJ, editors. Gene therapy in the central nervous system. San Diego: Elsevier. pp. 303-316.
8. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, et al. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28: 264-278.
9. Klugmann M, Symes CW, Klaussner BK, Leichtlein CB, Serikawa T, et al. (2003) Identification and distribution of aspartoacylase in the postnatal rat brain. Neuroreport 14: 1837-1840. (Pubitemid 37372614)
10. Madhavarao CN, Moffett JR, Moore RA, Viola RE, Namboodiri MA, et al. (2004) Immunohistochemical localization of aspartoacylase in the rat central nervous system. J Comp Neurol 472: 318-329. (Pubitemid 38420372)
11. Madhavarao CN, Arun P, Moffett JR, Szucs S, Surendran S, et al. (2005) Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Proc Natl Acad Sci U S A 102: 5221-5226.
12. Ahmed SS, Li H, Cao C, Sikoglu EM, Denninger AR, et al. (2013) A Single Intravenous rAAV Injection as Late as P20 Achieves Efficacious and Sustained CNS Gene Therapy in Canavan Mice. Mol Ther 21: 2136-2147.
13. Toriello HV, Reardon W, Gorlin RJ (2004) Hereditary Hearing Loss and Its Syndromes. New York: Oxford University Press.
14. Ochs R, Markand ON, DeMyer WE (1979) Brainstem auditory evoked responses in leukodystrophies. Neurology 29: 1089-1093. (Pubitemid 9188052)
15. Parhan K, Sun X-M, Kim DP (2001) Noninvasive assessment of auditory function in mice: Auditory brainstem response and distortion product otoacoustic emissions. In: Handbook of Mouse Audiotory Research from behavior to molecular biology. Ed. JF Willott. CRC Press, Boca Raton London. Chapter 4, pp. 37-58.
16. Cederholm JM, Froud KE, Wong AC, Ko M, Ryan AF, et al. (2012) Differential actions of isoflurane and ketamine-based anaesthetics on cochlear function in the mouse. Hear Res 292: 71-79.
17. Kluver H, Barrera E (1953) A method for the combined staining of cells and fibers in the nervous system. J Neuropathol Exp Neurol 12: 400-403.
18. von Jonquieres G, Mersmann N, Klugmann CB, Harasta AE, Lutz B, et al. (2013) Glial promoter selectivity following AAV-delivery to the immature brain. PLoS One 8: e65646.
19. Henry KR, Chole RA (1980) Genotypic differences in behavioral, physiological and anatomical expressions of age-related hearing loss in the laboratory mouse. Audiology 19: 369-383. (Pubitemid 10092915)
20. Mikaelian DO (1979) Development and degeneration of hearing in the C57/b16 mouse: relation of electrophysiologic responses from the round window and cochlear nucleus to cochlear anatomy and behavioral responses. Laryngoscope 89: 1-15.
21. Kemp DT (2002) Otoacoustic emissions, their origin in cochlear function, and use. Br Med Bull 63: 223-241.
22. Fishman MA (2006) Diseases with astrocyte abnormalities. In: McMillan JA, editor. Oski's Pediatrics: Principles and Practice. 4 ed: Lippincott Williams & Wilkins. pp. 2378-2379.
23. Ishiyama G, Lopez I, Baloh RW, Ishiyama A (2003) Canavan's leukodystrophy is associated with defects in cochlear neurodevelopment and deafness. Neurology 60: 1702-1704. (Pubitemid 36618110)
24. Zafeiriou DI, Kleijer WJ, Maroupoulos G, Anastasiou AL, Augoustidou-Savvopoulou P, et al. (1999) Protracted course of N-acetylaspartic aciduria in two non-Jewish siblings: identical clinical and magnetic resonance imaging findings. Brain Dev 21: 205-208. (Pubitemid 29206635)
25. Banker BQ, Robertson JT, Victor M (1964) Spongy Degeneration of the Central Nervous System in Infancy. Neurology 14: 981-1001.
26. Sacks O, Brown WJ, Aguilar MJ (1965) Spongy Degeneration of White Matter: Canavan's Sclerosis. Neurology 15: 165-171.
27. Suzuki K (1968) Peripheral nerve lesion in spongy degeneration of the central nervous system. Acta Neuropathol 10: 95-98.
28. Ory-Lavollee L, Blakely RD, Coyle JT (1987) Neurochemical and immunocytochemical studies on the distribution of N-acetyl-aspartylglutamate and N-acetyl-aspartate in rat spinal cord and some peripheral nervous tissues. J Neurochem 48: 895-899. (Pubitemid 17018725)
29. el Khateeb I, Abdul Razzak B, Moosa A (1988) Auditory brainstem responses (ABR) in children with neurological disorders. Brain Dev 10: 243-248.
30. Leuzzi V, Rinna A, Gallucci M, Di Capua M, Dionisi-Vici C, et al. (2000) Ataxia, deafness, leukodystrophy: inherited disorder of the white matter in three related patients. Neurology 54: 2325-2328. (Pubitemid 30416288)
31. van der Knaap MS, Valk J, Bakker CJ, Schooneveld M, Faber JA, et al. (1991) Myelination as an expression of the functional maturity of the brain. Dev Med Child Neurol 33: 849-857.
32. Kuan CC, Sano M, Kaga K, Kodama M, Kodama K (2008) Hearing profile and MRI myelination of auditory pathway in Pelizaeus-Merzbacher disease. Acta Otolaryngol 128: 539-546. (Pubitemid 351550958)
33. Brown FR, 3rd, Shimizu H, McDonald JM, Moser AB, Marquis P, et al. (1981) Auditory evoked brainstem response and high-performance liquid chromatography sulfatide assay as early indices of metachromatic leukodystrophy. Neurology 31: 980-985. (Pubitemid 11061736)
34. D'Hooge R, Coenen R, Gieselmann V, Lullmann-Rauch R, De Deyn PP (1999) Decline in brainstem auditory-evoked potentials coincides with loss of spiral ganglion cells in arylsulfatase A-deficient mice. Brain Res 847: 352-356.
35. Hess B, Saftig P, Hartmann D, Coenen R, Lullmann-Rauch R, et al. (1996) Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc Natl Acad Sci U S A 93: 14821-14826. (Pubitemid 26419053)